| COVID-19 |
1 |
1 |
| Child |
0 |
0.98 |
| Pain Management |
0 |
0.8 |
| Biomarker |
0 |
0.99 |
| Acute Respiratory Distress Syndrome |
0 |
0.29 |
| Genomic Medicine |
0 |
0.28 |
| MicroRNA |
0 |
0.97 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.26 |
| Cytokines |
0 |
0.19 |
| Mechanical Ventilation |
0 |
0.19 |
| Severe Acute Respiratory Syndrome |
0 |
0.96 |
| Hospital |
0 |
0.13 |
| Abdominal Pain |
0 |
0.11 |
| Cardiogenic Shock |
0 |
0.09 |
| Abdomen |
0 |
0.07 |
| Adolescent Medicine |
0 |
0.95 |
| Blood |
0 |
0.07 |
| Concussion |
0 |
0.07 |
| Extracorporeal Membrane Oxygenation (ECMO) |
0 |
0.07 |
| Fever |
0 |
0.07 |
| Geriatrics |
0 |
0.07 |
| Grant |
0 |
0.07 |
| Michigan |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Pneumonia |
0 |
0.07 |
| Respiratory Failure |
0 |
0.07 |
| Risk Management |
0 |
0.07 |
| Shock |
0 |
0.07 |
| Traumatic Brain Injury |
0 |
0.07 |